Our work on quantification of myocardial blood flow using rubidium-82 (82Rb) positron emission tomography (PET) is poised to provide accurate and precise clinical information for effective patient management. Modern technology has enabled us to substantially reduce the cost of this exams, reduce radiation exposures, and drive new applications. The lessons we learnt and the technologies we developed are now being translated to clinics around the world through industry partnerships. This talk will introduce our cutting edge 82Rb PET technology what we have done to make it more widely available.
- Become familiar with the benefits of myocardial blood flow quantification over traditional modalities.
- Understand why 82Rb PET is likely to make myocardial blood flow quantification more widely available.
- Understand the implications of these technologies for the nuclear medicine technologist.